Gregory D. Davis - 24 May 2025 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Role: Head of Research & Technology
Signature: /s/ Prathyusha Duraibabu, Attorney-in-Fact
Issuer symbol: SGMO
Transactions as of: 24 May 2025
Net transactions value: -$342
Form type: 4
Filing time: 28 May 2025, 16:05:12 UTC
Previous filing: 24 Apr 2025
Next filing: 24 Jul 2025
SEC: View on sec.gov

Key filing fact

Gregory D. Davis filed Form 4 for SANGAMO THERAPEUTICS, INC (SGMO) on 28 May 2025.

Key facts

This page summarizes Gregory D. Davis's Form 4 filing for SANGAMO THERAPEUTICS, INC (SGMO).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 28 May 2025, 16:05.

Change

Previous filing in this sequence was filed on 24 Apr 2025.
Current net transaction value: -$342.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0002041855 Primary reporting owner

Davis Gregory D

Relationship: Head of Research & Technology
Address: C/O SANGAMO THERAPEUTICS, INC., 501 CANAL BLVD., RICHMOND
Signature: /s/ Prathyusha Duraibabu, Attorney-in-Fact
Signature date: 28 May 2025

Transactions Table

SGMO transaction

Common Stock

Tax liability

Transaction value: $342
Shares: -723
Change %: -0.35%
Price: $0.4733
Shares after: 208,653
Date: 24 May 2025
Ownership: Direct
Footnotes: F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on May 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 23, 2025 of $0.4733/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
F2	Includes: (a) 1,298 shares resulting from the May 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 6,065 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 56,250 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 49,726 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Content

Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on May 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 23, 2025 of $0.4733/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.

Includes: (a) 1,298 shares resulting from the May 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 6,065 shares will vest in successive equal quarterly installments through February 24, 2026, (b) 56,250 shares subject to the Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 49,726 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.